A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy
Keywords: Llama antibodies; HER2; Anti-idiotypic vaccine;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort
Keywords: FISH; EGFR; HER2; KRAS; Biomarkers; NSCLC; Tyrosine inhibitors
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432
Keywords: Antibody response; NY-ESO-1; HER2;
A COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms
Keywords: PI3K; phosphatidylinositol 3-kinase; AKT; protein kinase B; PDK; phosphoinositide-dependent kinase; MAPK; mitogen activated protein kinase; COX-2; cyclooxygenase 2; NSAIDs; non-steroidal anti-inflammatory drugs; PGE2; prostaglandin E2; Her2; human epiderm
Analysis: Secretary's Advisory Committee on Genetics, Health, and Society Report falls short
Keywords: SACGHS; Secretary's Advisory Committee on Genetics Health and Society; Molecular diagnostics; Genetic testing; Pharmacogenetics; EGAPP; HER2; Laboratory regulation; CLIA; Food and drug administration; FDA; Proficiency testing; Laboratory developed tests;
Enhancement of antitumor immune response by targeted interleukin-12 electrogene transfer through antiHER2 single-chain antibody in a murine bladder tumor model
Keywords: Interleukin-12; HER2; Electrogene transfer
Evaluation of an anti-p185HER2 (scFv-CH2-CH3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-d-GEEEK
Keywords: HER2; Radioiodination; Monoclonal antibody; Internalization
Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies
Keywords: Antibody; Growth inhibition; HER2; Epitope mapping
The Coffey Lecture: Steroidogenic enzyme inhibitors and hormone dependent cancer
Keywords: Breast cancer; Xenograft models; Letrozole; Anastrozole; Her2; Trastuzumab
The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
Keywords: HER2; Metastasis; Breast cancer; Cancer stem cell; Untransformed cell
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of α-particle-emitting 211At-labeled trastuzumab
Keywords: Astatine-211; Radioimmunotherapy; Trastuzumab; HER2; Targeted radiotherapy
Increased topoisomerase IIα expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis
Keywords: Topisomerase II; Colorectal cancer; Oncology; Drug resistance; HER2; Colon cancer; Chemotherapy; Gene amplification; Cell cycle; Disease progression; Array CGH
Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
Keywords: ABC; ATP-binding cassette; BCRP; breast cancer resistance protein; CI; confidence interval; EGFR; epidermal growth factor receptor; FDA; Food and Drug Administration; HER2; human epidermal growth factor receptor 2; IRR; independent radiology review; MBC;
Recomendación para la determinación de HER2 en cáncer de mama. Consenso nacional de la Sociedad Española de Anatomía Patológica (SEAP) y de la Sociedad Española de Oncología Médica (SEOM)
Keywords: Cáncer de mama; HER2; inmunohistoquímica; hibridación in situ; estandarización; control de calidadBreast cancer; HER2 testing; immunohistochemistry; in situ hybridization; standardization; quality assessment
Therapeutic options for triple-negative breast cancers with defective homologous recombination
Keywords: ABC; ATP-binding cassette; APC; Adenomatous, polyposis coli; ATM; Ataxia telangiectasia mutated; ATR; ATM and Rad3-related; BER; base-excision repair; BRCA1; Breast cancer susceptibility gene 1; BRCA2; Breast cancer susceptibility gene 2; CGH; Comparative
A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: Design, synthesis, and biological activity
Keywords: EGFR; HER2; HER1; Kinase; Pyrimidine; Quinazoline mimic; Intramolecular hydrogen bond; Restricted rotation; Oxadiazole
The 2007 Rome Forum on the Treatment of Breast Cancer: first-line treatment choices for metastatic breast cancer in Europe
Keywords: Metastatic breast cancer; Hormone receptor; HER2;
Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90
Keywords: Hsp90; Heat shock protein 90; Cancer therapeutic; Cancer inhibitor; X-ray structure; Her2; ATP; Carbazol-4-one; Benzamide; Hsp70
HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients
Keywords: HER2; Breast cancer; Radiotherapy; Brain metastases
Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases
Keywords: HER2; Fluorescence in situ hybridization (FISH); Automated image analysis
Diagnostic de l’amplification du gène HER2 dans les cancers du sein: Le point de vue génétique
Keywords: Carcinome; Sein; HER2; Amplification; FISHCarcinoma; Breast; HER2; Amplification; FISH
Comparative expression analysis of four breast cancer subtypes versus matched normal tissue from the same patients
Keywords: Microarray; Gene expression; Estrogen receptor (ER); Her2
Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells
Keywords: Ets-1; HER2; MMP-1; Breast cancer
Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line
Keywords: Affibody molecule; Akt; Erk; HER2; Proliferation; Trastuzumab
Leptin Augments Proliferation of Breast Cancer Cells via Transactivation of HER2
Keywords: breast cancer; leptin; Her2; transactivation;
The prognostic importance of triple negative breast carcinoma
Keywords: Breast carcinoma; Triple negative; HER2; ER; PR
Characterization of breast cancer subtypes by quantitative assessment of biological parameters: Relationship with clinicopathological characteristics, biological features and prognosis
Keywords: Breast cancer; Epidermal growth factor receptor; HER1; HER2; Prognosis
Affinity-based entrapment of the HER2 receptor in the endoplasmic reticulum using an affibody molecule
Keywords: ER; Endoplasmic reticulum; scFv; single-chain fragment; MLV; murine leukemia virus; tdtd; doubling time; ErbB2; HER2; Affibody molecule; Endoplasmic reticulum; Flow cytometry;
Her2-positive breast cancer: Herceptin and beyond
Keywords: Her2; Breast cancer; Trastuzumab; Tyrosine kinase inhibitors; mTOR inhibitors
Bone metastasis is strongly associated with estrogen receptor–positive/progesterone receptor–negative breast carcinomas
Keywords: Breast cancer; Bone metastasis; Molecular subtypes; ER-α; PR; AR; HER2; Epidermal growth factor receptor; Cytokeratin markers
Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?
Keywords: Molecular classification; Invasive ductal carcinoma; Ductal carcinoma in situ; Nuclear grade; Cytokeratin markers; ER-α; PR; HER2
Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers
Keywords: Basal-like phenotype; Breast cancer; HER2; Prognosis
Radiolabeling of HER2-specific Affibody® molecule with F-18
Keywords: Fluorine-18; HER2; Breast cancer; Affibody® molecule
Molecular Mechanisms for Individualized Cancer Care
Keywords: EGFR; epidermal growth factor receptor; ERCC1; endonuclease excision repair cross-complementing 1; HER2; human epidermal growth factor receptor 2; NSCLC; non-small-cell lung cancer;
A novel perspective on designing the inhibitor of HER2 receptor
Keywords: HER2; Tyrosine kinase; Inhibitors; Docking; Molecular simulation
Chemotherapy in breast cancer patients with brain metastases: Have new chemotherapic agents changed the clinical outcome?
Keywords: Brain metastases; Breast cancer; Chemotherapy; HER2; Review; Trastuzumab
Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells Is a Primary Target for Therapy with Tyrosine Kinase Inhibitors
Keywords: EGF; epidermal growth factor; >EGFR; EGF receptor; HER2; human epidermal growth factor receptor 2; PKI166; 4-[R]-phenethylamino-6-[hydroxyl] phenyl-7H-pyrrolo [2,3-d]-pyrimidine; shRNA; small hairpin RNA; TGF; transforming growth factor; TKI; tyrosine kin
Multifunctional poly(d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer
Keywords: Biodegradable polymers; Cancer nanotechnology; Medical clay; Nanomedicine; Herceptin; HER2
Targeted therapies in breast cancer
Keywords: Breast cancer; Targeted therapy; Immunohistochemistry; FISH; HER2; Estrogen receptor;
The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies
Keywords: Basal subtype of breast carcinomas; Breast cancer; EGFR; HER2; Targeted therapies
EGFR gene and protein expression in breast cancers
Keywords: Breast cancer; EGFR1; HER2; Prognosis
Development of real-time quantitative reverse transcription-PCR for Her2 detection in peripheral blood from patients with breast cancer
Keywords: Breast cancer; Tumoral markers; HER2; Quantitative PCR; IHC
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: A clue to uncover the mechanisms of trastuzumab-related cardiotoxicity
Keywords: Trastuzumab; Cardiotoxicity; Breast cancer; Molecular imaging; HER2
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases
Keywords: Pyrrolotriazine; EGFR; HER2; Kinase inhibitor
The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer
Keywords: erbB2; Her2; Anilinoquinazoline; Kinase; Cancer
EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)
Keywords: epidermal growth factor receptor; HER2; Akt; Chemotherapy; Tyrosine kinase inhibitor; Non-small cell lung cancer
Using clinical trial data to tailor adjuvant treatments for individual patients
Keywords: Breast cancer; Subgroup analysis; Estrogen receptors; Progesterone receptors; HER2; Adjuvant therapy; Chemotherapy; Endocrine therapy; Trastuzumab; STEPP
Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer
Keywords: HER2; Immunohistochemistry; Chromogenic in situ hybridization; Metastatic breast cancer; Prognosis; Progression-free interval
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases
Keywords: EGFR; HER2; Receptor tyrosine kinase inhibitor; Pyrrolotriazine